Till Wallrabenstein
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 2
- Cancer Immunotherapy and Biomarkers 2
- Colorectal Cancer Treatments and Studies 1
-
- Lung Cancer Treatments and Mutations 1
- Co-authors
- Heinz Läubli (1 shared paper)Laura C. Cappelli (1 shared paper)Alfred Zippelius (1 shared paper)David König (2 shared papers)Jarushka Naidoo (1 shared paper)Martin Buess (1 shared paper)Arnoud J. Templeton (1 shared paper)Christoph Rochlitz (1 shared paper)
- Journals
- PLoS ONE (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Cancer Medicine (1 paper)JTO Clinical and Research Reports (1 paper)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Till Wallrabenstein
4 papers receiving 38 citations
Peers
Comparison fields: 5 of 21
- Oncology 26
- Geriatrics and Gerontology 1
- Hepatology 2
- Pulmonary and Respiratory Medicine 6
- Pathology and Forensic Medicine 2
Countries citing papers authored by Till Wallrabenstein
This map shows the geographic impact of Till Wallrabenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Till Wallrabenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Till Wallrabenstein more than expected).
Fields of papers citing papers by Till Wallrabenstein
This network shows the impact of papers produced by Till Wallrabenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Till Wallrabenstein. The network helps show where Till Wallrabenstein may publish in the future.
Co-authors
The 11 scholars most cited alongside Till Wallrabenstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 28 | |
| 2 | 2020 | 6 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 2 |
About Till Wallrabenstein
Till Wallrabenstein is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Infectious Diseases, Organic Chemistry and Surgery, having authored 4 papers that have together received 39 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (2 papers), Lung Cancer Treatments and Mutations (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Oncology (26 citations), Geriatrics and Gerontology (1 citation), Hepatology (2 citations), Pulmonary and Respiratory Medicine (6 citations) and Pathology and Forensic Medicine (2 citations). Till Wallrabenstein has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Heinz Läubli, Laura C. Cappelli, Alfred Zippelius, David König, Jarushka Naidoo, Martin Buess, Arnoud J. Templeton, Christoph Rochlitz, Anton Oseledchyk and Marcus Vetter. Their work appears in journals such as PLoS ONE, Journal for ImmunoTherapy of Cancer, Cancer Medicine and JTO Clinical and Research Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.